Pre-analytical Influences on a Blood Test Study - Trial NCT05434949
Access comprehensive clinical trial information for NCT05434949 through Pure Global AI's free database. This phase not specified trial is sponsored by The Royal Wolverhampton Hospitals NHS Trust and is currently Not yet recruiting. The study focuses on IBS - Irritable Bowel Syndrome. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
The Royal Wolverhampton Hospitals NHS Trust
Timeline & Enrollment
N/A
Dec 01, 2022
Dec 01, 2024
Primary Outcome
Serum C4 will be measured by liquid chromatography tandem mass spectrometry (LC-MS/MS) to measure increase/ decrease by diurnal variation and food intake.,Measure increase/decrease in Serum C4 levels after taking lipid lowering therapy (statins / PCSK9 inhibitors).
Summary
Chronic diarrhoea is common and often believed to result from irritable bowel syndrome (IBS).
 However, up to 50% of patients with an IBS diagnosis may have something called Bile Acid
 Diarrhoea (BAD) instead. BAD is easily treatable however diagnosis currently relies on a
 complex test involving two full body scans. The aim of the study is therefore to investigate
 whether a simple laboratory test, that can be done on a single blood sample, would be
 appropriate instead. This laboratory test is called 7aC4.
 
 In order to determine whether 7aC4 could be a good test for BAD, it needs to be determined
 whether eating a meal can alter the levels of 7aC4. The aim of this study is to measure 7aC4
 at several time points before and after eating a meal, to see what effect this has on 7aC4
 levels.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05434949
Non-Device Trial